Science Explorer Back to mapMap
Discussion
Researcher · Simcere Pharmaceutical (China) · China

Guimei Yang

Guimei Yang publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Aquaculture disease management and microbiota, Advanced Breast Cancer Therapies and Protein Degradation and Inhibitors.

ORCID 0000-0003-3714-529X OpenAlex
World rank
#6,481,330
of 7,710,434 ranked researchers
Rank in China
#889,346
of 978,568
Works
59
Citations
477
Citations per work
8.1
h-index
11
i10-index 13Top 71% in Molecular Biology
Guimei Yang

What does Guimei Yang research?

Guimei Yang's work is mostly in Biochemistry, Genetics and Molecular Biology (28%), Medicine (21%), Immunology and Microbiology (6%).

Everything else: 27 works · 45.1% of their workLife Sciences: 20 works · 34.2% of their workBiochemistry, Genetics and Molecular Biology: 17 works · 28.1% of their workMolecular Biology: 14 works · 24.4% of their workCancer Research: 2 works · 3.7% of their workImmunology and Microbiology: 4 works · 6.1% of their workImmunology: 4 works · 6.1% of their workHealth Sciences: 12 works · 20.7% of their workMedicine: 12 works · 20.7% of their workOncology: 5 works · 9.1% of their workPulmonary and Respiratory Medicine: 4 works · 7.3% of their workEpidemiology: 3 works · 4.3% of their workTHEIR WORKGuimei Yang59works
Life Sciences34%Health Sciences21%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2745.1%
    1. Biochemistry, Genetics and Molecular Biology1728.1%
    2. Immunology and Microbiology46.1%
    1. Medicine1220.7%
  1. 1Molecular Biology24% of their works
  2. 2Oncology9% of their works
  3. 3Pulmonary and Respiratory Medicine7% of their works
  4. 4Immunology6% of their works
  5. 5Epidemiology4% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Guimei Yang's research?

The keywords of their largest research topics: Transcriptional Regulation, Breast Cancer, Aquaculture, CDK4/6 Inhibitors, Fish Immunology, Palbociclib, BET Bromodomains and PROTACs.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Transcriptional Regulation113 topics
  2. Breast Cancer92 topics
  3. Aquaculture61 topic
  4. CDK4/6 Inhibitors61 topic
  5. Fish Immunology61 topic
  6. Palbociclib61 topic
  7. BET Bromodomains51 topic
  8. PROTACs51 topic
  9. Energetic Salts41 topic
  10. Immune Checkpoint Blockade41 topic
  11. PD-1 and PD-L141 topic
  12. ReaxFF41 topic
  13. Arginine Methylation31 topic
  14. Bacterial Therapy31 topic
  15. Estrogen31 topic
  16. Protein Arginine Methyltransferases31 topic
  17. Receptor31 topic
  18. Tumor Targeting31 topic

Where does Guimei Yang work?

Guimei Yang's main affiliation in the publication record is Simcere Pharmaceutical (China), China.

How many publications and citations does Guimei Yang have?

OpenAlex counts 59 works and 477 citations for Guimei Yang, an h-index of 11, ranking #6,481,330 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Guimei Yang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.